Copanlisib in Combination With Rituximab and CHOP Chemotherapy in Patients With Previously Untreated DLBCL

NCT04263584 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
62
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Hospital Muenster

Collaborators